ArticlePharmaceuticals (Basel, Switzerland)2024

Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study.

Zihan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.